Suehiro S, Shibata T, Sasaki Y, Murakami T, Hosono M, Fujii H, Kinoshita H
Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585.
Ann Thorac Cardiovasc Surg. 1999 Dec;5(6):376-81.
This study was designed to evaluate the operative outcome of dialysis patients undergoing cardiac surgery. A retrospective review was performed of 28 consecutive patients with end-stage renal disease dependent on maintenance hemodialysis (n = 26) or peritoneal dialysis (n = 2) who underwent cardiopulmonary bypass (CPB). The operations included isolated coronary artery bypass grafting (CABG) (n = 21), aortic valve replacement (n = 4) and CABG plus aortic valve replacement (n = 3). Seven operations were emergent or urgent. In 23 patients, a heparin-coated (HC) circuit with reduced systemic heparinization was used for CPB. The hospital mortality was 7.1%. Complications occurred in 13 patients (46%). Although thoracotomy for bleeding was required in 3 patients, only 1 had undergone CPB with an HC circuit. There were 7 late deaths. All survivors showed improvement in symptoms and overall functional status. The actuarial survival rates were 78% and 58% at 1 and 4 years, respectively. In the 10 patients with diabetes mellitus, the 4-year survival rate was 50%. In the patients who underwent non-elective surgery, the survival rate was 29%. Cardiac surgery can be performed with increased but acceptable mortality in dialysis patients. Good symptomatic relief can be expected. Surgery should be performed before the general condition deteriorates.
本研究旨在评估接受心脏手术的透析患者的手术结局。对28例接受体外循环(CPB)的终末期肾病患者进行了回顾性研究,这些患者均依赖维持性血液透析(n = 26)或腹膜透析(n = 2)。手术包括单纯冠状动脉旁路移植术(CABG)(n = 21)、主动脉瓣置换术(n = 4)以及CABG加主动脉瓣置换术(n = 3)。7例手术为急诊或紧急手术。23例患者在CPB时使用了肝素涂层(HC)回路并减少了全身肝素化。医院死亡率为7.1%。13例患者(46%)出现并发症。尽管3例患者因出血需要开胸手术,但仅1例在CPB时使用了HC回路。有7例晚期死亡。所有幸存者的症状和整体功能状态均有所改善。1年和4年的精算生存率分别为78%和58%。10例糖尿病患者的4年生存率为50%。接受非择期手术的患者生存率为29%。透析患者进行心脏手术时死亡率虽有所增加但仍可接受。有望获得良好的症状缓解。应在一般状况恶化之前进行手术。